Since CD103+CD8+ TRM cells in primary CRC correlated with a favorable prognosis [16], and CD103+CD39+CD8+ TILs have been described as tumor-reactive in various solid tumors [11,12], we assessed T cells by detecting these markers. The gene discussed is ENTPD1; the disease is neoplasm.